Weedoweed Group Sdn Bhd (WDW) is the first registered pharmaceutical company that focuses on cannabis healthcare products. With clinical trials completed globally providing the safety and efficacy of the chemical compounds found in cannabis plants like Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC) for a range of illnesses like epilepsy (Dravet's syndrome), severe pain, Alzheimer's disease and more, the need and demand for the right products is growing immensely in Malaysia.
WDW has planned a clear pathway from research to market and has also obtained official letters from the government, PMO and KKM that supports our direction. The business may need to start with a low cost and short human clinical trial (est.: 6 months) with our first product choice to prove its medical benefits and safety. However with a team of scientific experts in the cannabis field, WDW is ready and confident that the processes could be completed with ease to allow the first product to be sold by 2020 and the company to grow into a producer within three years.
Our vision is to provide the best quality cannabis healthcare products at affordable prices to all Malaysians that could possibly save the lives of thousands in return.
Weedoweed Group Sdn Bhd doesn't have any updates to show yet.
Please login or sign up to see the discussions.